发明公开
EP1678178A1 NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES
审中-公开
新DIAZASPIROALKANE和它们在疾病治疗的介导CCR8
- 专利标题： NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES
- 专利标题（中）： 新DIAZASPIROALKANE和它们在疾病治疗的介导CCR8
-
申请号： EP04793824.6申请日： 2004-10-21
-
公开(公告)号： EP1678178A1公开(公告)日： 2006-07-12
- 发明人: BLADH, Hakan , CONNOLLY, Stephen, AstraZeneca R & D Charnwood , DYKE, Hazel Joan, Argenta Discovery Ltd. , LISIUS, Annea , PRICE, Stephen, Argenta Discovery Ltd. , SHAMOVSKY, Igor , VAN DEN HEUVEL, Marco, Argenta Discovery Ltd.
- 申请人： AstraZeneca AB
- 申请人地址： 151 85 Södertälje SE
- 专利权人： AstraZeneca AB
- 当前专利权人： AstraZeneca AB
- 当前专利权人地址： 151 85 Södertälje SE
- 优先权： SE0302811 20031023
- 国际公布： WO2005040167 20050506
- 主分类号： C07D471/10
- IPC分类号： C07D471/10 ; A61K31/438 ; A61P11/06
摘要：
The invention provides compounds of general formula. wherein A, B, W, X, Y, Z, D, E, R1 and n are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
信息查询
